Pascal and Francis Bibliographic Databases


Search results

Your search

au.\*:("CHERRINGTON, J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 40

  • Page / 2

Selection :

  • and

Finiteness and dual variables for Lorentzian spin foam modelsWADE CHERRINGTON, J.Classical and quantum gravity (Print). 2006, Vol 23, Num 3, pp 701-719, issn 0264-9381, 19 p.Article

Regulation of polyadenylation in human immunodeficiency virus (HIV): contributions of promoter proximity and upstream sequencesCHERRINGTON, J; GANEM, D.EMBO journal (Print). 1992, Vol 11, Num 4, pp 1513-1524, issn 0261-4189Article

Efficacy and safety of Adefovir dipivoxil with antiretroviral therapy : A randomized controlled trialKAHN, J; LAGAKOS, S; BASGOZ, N et al.JAMA, the journal of the American Medical Association. 1999, Vol 282, Num 24, pp 2305-2312, issn 0098-7484Article

The Oxidation and Interdiffusion of a Chromia Forming Multilayered TBC SystemSMITH, P. J. R; TAYLOR, M. P; EVANS, H. E et al.Oxidation of metals. 2014, Vol 81, Num 1-2, pp 47-55, issn 0030-770X, 9 p.Conference Paper

Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS. Editorial ResponseJACOBSON, M. A; WILSON, S; STANLEY, H et al.Clinical infectious diseases. 1999, Vol 28, Num 3, pp 528-536, issn 1058-4838Conference Paper

Upstream sequences and cap proximity in the regulation of polyadenylation in ground squirrel hepatitis virusCHERRINGTON, J; RUSSNAK, R; GANEM, D et al.Journal of virology. 1992, Vol 66, Num 12, pp 7589-7596, issn 0022-538XArticle

Anti-HIV activity of adefovir (PMEA) and PMPA in combination with antiretroviral compounds : in vitro analysesMULATO, A. S; CHERRINGTON, J. M.Antiviral research. 1997, Vol 36, Num 2, pp 91-97, issn 0166-3542Article

Positivity in Lorentzian Barrett-Crane models of quantum gravityCHERRINGTON, J. Wade; CHRISTENSEN, J. Daniel.Classical and quantum gravity (Print). 2006, Vol 23, Num 3, pp 721-736, issn 0264-9381, 16 p.Article

Human cytomegalovirus ie1 transactivates the α promoter-enhancer via an 18-base-pair repeat elementCHERRINGTON, J. M; MOCARSKI, E. S.Journal of virology. 1989, Vol 63, Num 3, pp 1435-1440, issn 0022-538XArticle

Manual control of crane systemsSUTTON, R; CHERRINGTON, J. E; TOWILL, D. R et al.Ergonomics. 1986, Vol 29, Num 10, pp 1155-1171, issn 0014-0139Article

Anti-HCMV activity of cidofovir in combination with antiviral compounds and immunosuppressive agents : in-vitro analysesMULATO, A. S; CHERRINGTON, J. M; CHEN, M. S et al.Antiviral chemistry & chemotherapy. 1996, Vol 7, Num 4, pp 203-208, issn 0956-3202Article

A rapid antiviral in situ enzyme-linked immunosorbent assay for feline immunodeficiency virusSMITH, J. L; ALLEN, S. J. W; CHERRINGTON, J. M et al.Journal of virological methods. 1995, Vol 54, Num 1, pp 29-38, issn 0166-0934Article

Human cytomegalovirus ie2 negatively regulates α gene expression via a short target sequence near the transcription start siteCHERRINGTON, J. M; KHOURY, E. L; MOCARSKI, E. S et al.Journal of virology. 1991, Vol 65, Num 2, pp 887-896, issn 0022-538X, 10 p.Article

Virological, clinical and serological responses of sheep infected with tissue culture adapted bluetongue virus serotypes 10, 11, 13 and 17GHALIB, H. W; CHERRINGTON, J. M; OSBURN, B. I et al.Veterinary microbiology (Amsterdam). 1985, Vol 10, Num 2, pp 179-188, issn 0378-1135Article

Novel mutation (K70E) in human immunodeficiency virus type 1 reverse transcriptase confers decreased susceptibility to 9-[2-(phosphonomethoxy)ethyl]adenine in vitroCHERRINGTON, J. M; MULATO, A. S; FULLER, M. D et al.Antimicrobial agents and chemotherapy. 1996, Vol 40, Num 9, pp 2212-2216, issn 0066-4804Article

Kinetic interaction of the diphosphate of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active purine congeners with HIV reverse transcriptase and human DNA poluymerases α, β and γCHERRINGTON, J. M; ALLEN, S. J. W; BISCHOFBERGER, N et al.Antiviral chemistry & chemotherapy. 1995, Vol 6, Num 4, pp 217-221, issn 0956-3202Article

Physiological factors affecting protein expression of flavin-containing monooxygenases 1, 3 and 5CHERRINGTON, N. J; YAN CAO; CHERRINGTON, J. W et al.Xenobiotica (London. Print). 1998, Vol 28, Num 7, pp 673-682, issn 0049-8254Article

Detection of viral antigens in bluetongue virus-infected ovine tissues, using the peroxidase-antiperoxidase techniqueCHERRINGTON, J. M; GHALIB, H. W; SAWYER, M. M et al.American journal of veterinary research. 1985, Vol 46, Num 11, pp 2356-2359, issn 0002-9645Article

Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γCHERRINGTON, J. M; ALLEN, S. J; MCKEE, B. H et al.Biochemical pharmacology. 1994, Vol 48, Num 10, pp 1986-1988, issn 0006-2952Article

NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulationSAMBUCETTI, L. C; CHERRINGTON, J. M; WILKINSON, G. W. G et al.EMBO journal (Print). 1989, Vol 8, Num 13, pp 4251-4258, issn 0261-4189Article

In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy : Relationship to clinical outcomeCHERRINGTON, J. M; FULLER, M. D; LAMY, P. D et al.The Journal of infectious diseases. 1998, Vol 178, Num 6, pp 1821-1825, issn 0022-1899Article

Quantitative changes in cytomegalovirus DNAemia and genetic analysis of the UL97 and UL54 genes in AIDS patients receiving cidofovir following ganciclovir therapyBOWEN, E. F; CHERRINGTON, J. M; LAMY, P. D et al.Journal of medical virology. 1999, Vol 58, Num 4, pp 402-407, issn 0146-6615Article

High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genesSMITH, I. L; CHERRINGTON, J. M; JILES, R. E et al.The Journal of infectious diseases. 1997, Vol 176, Num 1, pp 69-77, issn 0022-1899Article

Inhibition of HIV-1 RNase H activity by nucleotide dimers and monomersALLEN, S. J. W; KRAWCZYK, S. H; MCGEE, L. R et al.Antiviral chemistry & chemotherapy. 1996, Vol 7, Num 1, pp 37-45, issn 0956-3202Article

Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitroMILLER, M. D; ANTON, K. E; MULATO, A. S et al.The Journal of infectious diseases. 1999, Vol 179, Num 1, pp 92-100, issn 0022-1899Article

  • Page / 2